Live macrophages loaded with Fe3O4 and sulfasalazine for ferroptosis and photothermal therapy of rheumatoid arthritis

• Published in: Materials today bio 2024-02, Vol.24, p.100925-100925, Article 100925
• Main Authors: Ruan, Li, Cai, Xinxi, Qian, Rui, Bei, Shifang, Wu, Lin, Cao, Jin, Shen, Song
• Format: Article
• Language: English
• Subjects: Drug delivery; Ferroptosis; Full Length; Iron oxide nanoparticles; Macrophages; Photothermal therapy; Rheumatoid arthritis
• ISSN: 2590-0064; 2590-0064
• DOI: 10.1016/j.mtbio.2023.100925

Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized by the infiltration of inflammatory cells and proliferation of synovial cells. It can cause cartilage and bone damage as well as disability and is regarded as an incurable chronic disease. Available therapies cannot prevent the development of diseases due to the high toxicity of the therapeutic agents and the inefficient drug delivery. Ferroptosis, an iron-dependent manner of lipid peroxidative cell death, indicates great potential for RA therapy due to ability to damage the infiltrated inflammatory cells and proliferated fibroblast-like synoviocytes. Here, we use macrophages as vector to deliver Fe3O4 nanoparticles and sulfasalazine (SSZ) for ferroptosis and photothermal therapy of RA. The inherent property of migration towards the inflamed joints under the guidance of inflammatory factors enables macrophages to targetedly deliver the payload into the RA. Upon the irradiation of the near infrared light, the Fe3O4 nanoparticles convert the light into heat to damage the proliferated synovium. Meanwhile, the iron released from Fe3O4 nanoparticles works with SSZ to generate synergetic ferroptosis effect. The resident inflammatory cells and proliferated synovium are efficiently damaged by the ferroptosis and photothermal effect, showing pronounced therapeutic effect for RA. [Display omitted]